The above studies demonstrated that CIB2 acts as a negative regulator of mTORC1, and hence, we reasoned that CIB2 overexpression may partially downregulate the hyperactivated mTORC1 signaling observed in TSC and LAM. This evidence concerns the gene TSC1 and lymphangioleiomyomatosis.